|
AT500019B1
(de)
*
|
2001-06-27 |
2007-06-15 |
Inst Gefaessbiologie Und Throm |
Verwendung in vitro des transkriptionsfaktors nak-1 oder von nak-1 regulierten genen zur diagnose von entzündlichen und malignen erkrankungen
|
|
GB0406330D0
(en)
*
|
2004-03-20 |
2004-04-21 |
Univ Sheffield |
Gene screen
|
|
EP2029769A1
(en)
*
|
2006-05-25 |
2009-03-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating graft rejection and inflammatory conditiions
|
|
US8389207B2
(en)
*
|
2006-06-08 |
2013-03-05 |
Salk Institute For Biological Studies |
Methods for identifying candidate fat-mobilizing agents
|
|
WO2008118626A2
(en)
*
|
2007-03-08 |
2008-10-02 |
Burnham Institute For Medical Research |
Inhibitors of jnk and methods for identifying inhibitors of jnk
|
|
GB0707270D0
(en)
*
|
2007-04-16 |
2007-05-23 |
Univ Sheffield |
Modulation of cellular proliferation
|
|
GB0712087D0
(en)
*
|
2007-06-22 |
2007-08-01 |
Univ Sheffield |
Modulation of inflamation
|
|
WO2012075326A2
(en)
*
|
2010-12-01 |
2012-06-07 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Treatment of inflammatory diseases by targeting the adaptor protein ciks
|
|
US9920357B2
(en)
*
|
2012-06-06 |
2018-03-20 |
The Procter & Gamble Company |
Systems and methods for identifying cosmetic agents for hair/scalp care compositions
|
|
JP2015222174A
(ja)
*
|
2012-09-13 |
2015-12-10 |
学校法人 久留米大学 |
炎症性疾患を処置するため薬剤のスクリーニング方法
|
|
CN104740605B
(zh)
*
|
2013-12-25 |
2017-02-22 |
胡卓伟 |
一种多肽在制备治疗或预防代谢综合征的药物中的应用
|
|
AU2017207341A1
(en)
|
2016-01-12 |
2018-08-02 |
Interleukin Genetics, Inc. |
Methods for predicting response to treatment
|
|
US10329620B2
(en)
|
2017-01-12 |
2019-06-25 |
Cardioforecast Ltd. |
Methods and kits for treating cardiovascular disease
|
|
US20220249660A1
(en)
|
2019-06-06 |
2022-08-11 |
Sitokine Limited |
Compositions and methods for treating lung, colorectal and breast cancer
|
|
WO2021028469A1
(en)
|
2019-08-12 |
2021-02-18 |
Sitokine Limited |
Compositions and methods for treating cytokine release syndrome and neurotoxicity
|
|
WO2021205013A1
(en)
|
2020-04-09 |
2021-10-14 |
Sitokine Limited |
Compositions and methods for treating covid-19
|